Hussman’s Discreet Retreat from TG Therapeutics

The position, which previously accounted for a mere 1.0% of Hussman’s assets under management – a rounding error in the grand scheme, really – has vanished. One imagines the portfolio managers, with a sigh of resignation, reallocating the funds to something less… problematic. The markets, of course, remain impervious to such personal dramas.








